Request Sample
Request Methodology
Description
Market Dynamics: Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market
Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases, expansion of business by the companies in Middle east region, economic growth, and prolonged efficiency of transcatheter pulmonary valves are anticipated to propel the Middle East and Africa transcatheter pulmonary valve (TPV) therapy market over the forecast years. However, stringent regulations for product approval, lack of awareness in underdeveloped countries, and high cost of therapy may hamper the growth of Middle East and Africa transcatheter pulmonary valve (TPV) therapy market.
Market Scope: Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market
Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented on the basis of product type, end user, and country
Based on the product type, the market is segmented into the following:
- Valves
- Delivery System
Based on the end user, the market is segmented into the following:
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
Based on the country, the market is segmented into the following:
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Regional Analysis: Transcatheter Pulmonary Valve (TPV) Therapy Market
Geographically, Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries transcatheter pulmonary valve therapy market is growing at significant rate due to entry of companies into Middle East region, increase in healthcare expenditure, and rise in adoption of newer devices are anticipated to fuel the market. South Africa transcatheter pulmonary valve therapy market has a significant share due increase in awareness about transcatheter valves efficiency, rising healthcare expenditure, and rise in prevalence of congenital heart disease are bolster the market.
Competition Assessment: Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market
Some of the players in the Middle East and Africa transcatheter pulmonary valve (TPV) therapy market include:
- Venus MedTech (China)
- Inova (U.S.)
- Edward Lifesciences (U.S.)
- Medtronic Plc. (Ireland)
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and start-up’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Location
GEOGRAPHY
